マーケットレポート詳細
ヒトマイクロバイオームの世界市場：タイプ別、製品別2029年予測
Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2029
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年4月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文182ページになります。
- 商品コード：MAM2914
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ヒトマイクロバイオームの世界市場規模は2023年で2億6900万ドル、2029年に13億7000万ドル、市場の平均年成長率は31.1%に達すると推測されます。
レポートはヒトマイクロバイオームの世界市場について2029年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（用途別市場、製品別市場、等）を中心に構成されています。また競合状況、主要企業情報（18社）、市場ダイナミクス、特許分析などの分析も加味し、ヒトマイクロバイオーム市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆ヒトマイクロバイオームの世界市場予測2023-2029年
・市場規模(US$)
◆用途別、市場-2029年
・治療
・診断
※(市場規模US$)
◆技術別、市場-2029年
ゲノミクス
・シーケンシング
-16S rRNAシーケンシング
-全ゲノムシーケンシング(WGS)
-その他シーケンシング
・その他ゲノミクス技術
プロテオミクス
メタボロミクス
※(研究支出Research Spending Market、市場規模US$)
◆タイプ別、市場-2029年
・FMT(糞便微生物叢移植)
・ペプチド
・LBP(生きた生物学的製剤)
・その他
※(市場規模US$)
◆製品別、市場-2029年
・薬剤
・診断検査
・プロバイオティクス
・プレバイオティクス
・その他製品
※(市場規模US$)
◆疾患別、市場-2029年
・感染症
・胃腸疾患
・内分泌/代謝障害
・癌
・その他疾患
※(市場規模US$)
◆主要国地域別市場-2029年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・COVID-19の影響
・特許分析
・競合状況
◆ヒトマイクロバイオームの主要企業プロフィール動向
・ENTEROME
・SERES THERAPEUTICS
・4D PHARMA PLC
・INTERNATIONAL FLAVORS & FRAGRANCES INC.
・OPTIBIOTIX HEALTH PLC.
・SYNLOGIC, INC.
・SECOND GENOME INC.
・VEDANTA BIOSCIENCES, INC.
・FERRING PHARMACEUTICALS
・EVELO BIOSCIENCES, INC.
・BIOMX
・YSOPIA BIOSCIENCE
・KALEIDO BIOSCIENCES, INC.
・FLIGHTPATH BIOSCIENCES, INC.
・FINCH THERAPEUTICS GROUP, INC.
・QUANTBIOME, INC. (DBA OMBRE)
・VIOME LIFE SCIENCES, INC.
・BIOHM HEALTH
（その他企業）
・DAYTWO
・ATLAS BIOMED
・BIONE
・LUXIA SCIENTIFIC
・METABIOMICS
・SUN GENOMICS
（全182頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 MARKETS COVERED FOR HUMAN MICROBIOME
RESEARCH SPENDING MARKET
1.3.3 YEARS COVERED FOR THE STUDY (HUMAN MICROBIOME
RESEARCH SPENDING MARKET)
1.3.4 YEARS COVERED FOR THE STUDY (HUMAN MICROBIOME MARKET)
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.2 PRIMARY SOURCES.. 33
・ FIGURE 1......... BREAKDOWN OF PRIMARIES: HUMAN MICROBIOME MARKET
2.2 MARKET DATA ESTIMATION AND TRIANGULATION
・ FIGURE 2.......................... DATA TRIANGULATION METHODOLOGY
2.2.1 MARKET ESTIMATION METHODOLOGY
・ FIGURE 3..... MARKET SIZE ESTIMATION APPROACH: R&D SPENDING ANALYSIS-BASED ESTIMATION (FOR HUMAN MICROBIOME RESEARCH SPENDING MARKET)
・ FIGURE 4 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE
(USD MILLION): FINAL MARKET SIZE
2.2.2 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
・ FIGURE 5....................... FINAL CAGR PROJECTIONS (2023−2029)
2.2.3 POTENTIAL MARKET SIZE CALCULATION FOR HUMAN MICROBIOME MARKET
・ FIGURE 6............... HUMAN MICROBIOME MARKET SIZE BASED ON EPIDEMIOLOGY APPROACH
2.3 INSIGHTS FROM PRIMARIES
・ FIGURE 7............... MARKET VALIDATION FROM PRIMARY EXPERTS
2.4 RESEARCH ASSUMPTIONS
3.... EXECUTIVE SUMMARY
・ FIGURE 8................ HUMAN MICROBIOME MARKET, BY PRODUCT,
2023 VS. 2029 (USD MILLION)
・ FIGURE 9.. HUMAN MICROBIOME MARKET SHARE, BY APPLICATION, 2029
・ FIGURE 10.... HUMAN MICROBIOME MARKET, BY DISEASE, 2024 VS. 2029 (USD MILLION)
・ FIGURE 11..... GEOGRAPHICAL SNAPSHOT OF HUMAN MICROBIOME MARKET
4.... PREMIUM INSIGHTS
4.1 HUMAN MICROBIOME: MARKET OVERVIEW
・ FIGURE 12.............. INCREASING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET GROWTH
4.2 HUMAN MICROBIOME MARKET, BY TYPE (2023 VS. 2029)
・ FIGURE 13...... FMT TO DOMINATE HUMAN MICROBIOME MARKET IN 2023
4.3 NORTH AMERICA: HUMAN MICROBIOME MARKET, BY PRODUCT & APPLICATION (2023). 43
4.4 HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY COUNTRY (2023–2029)
・ FIGURE 14............ CHINA TO GROW AT THE HIGHEST CAGR DURING FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 15.. HUMAN MICROBIOME MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 RISING INDUSTRY-ACADEMIA COLLABORATIONS FOR MICROBIOME RESEARCH.. 47
5.2.1.2 INCREASING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT
5.2.1.3 HUMAN MICROBIOME AS A VALIDATED TARGET FOR DRUG DEVELOPMENT
5.2.1.4 DEVELOPMENT OF HUMAN MICROBIOME-BASED TESTS FOR EARLY DISEASE DETECTION & DIAGNOSIS
5.2.2 MARKET RESTRAINTS.. 49
5.2.2.1 BARRIERS IN PROVING THE CAUSAL LINK BETWEEN DYSBIOSIS AND DISEASES.. 49
5.2.2.2 NEGATIVE CLINICAL DATA WILL ADVERSELY IMPACT PUBLIC PERCEPTION OF MICROBIOMES
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 INCREASING COLLABORATIONS BETWEEN PUBLIC-PRIVATE ORGANIZATIONS
5.2.4 MARKET CHALLENGES.. 51
5.2.4.1 GOVERNMENT REGULATIONS
5.2.4.2 LACK OF EXPERTISE AND INADEQUATE RESEARCH
5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE HUMAN MICROBIOME MARKET
5.4 REGULATORY ANALYSIS.. 53
5.4.1 REGULATORY LANDSCAPE FOR HUMAN MICROBIOME-BASED DRUGS
5.4.2 REGULATORY LANDSCAPE FOR HUMAN MICROBIOME-BASED FOODS
5.5 PATENT ANALYSIS
6.... HUMAN MICROBIOME MARKET, BY APPLICATION
6.1 INTRODUCTION
・ TABLE 1.............. HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
6.2 THERAPEUTIC APPLICATIONS
6.2.1 AVAILABILITY OF FUNDING FOR MICROBIOME-BASED THERAPEUTIC PRODUCTS DEVELOPMENT TO DRIVE MARKET GROWTH
・ TABLE 2....... HUMAN MICROBIOME MARKET FOR THERAPEUTICS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 3........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR THERAPEUTICS,
BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 4................... EUROPE: HUMAN MICROBIOME MARKET FOR THERAPEUTICS, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 5............. ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR THERAPEUTICS,
BY COUNTRY 2023–2029 (USD MILLION)
6.3 DIAGNOSTIC APPLICATIONS
6.3.1 INCREASING FOCUS ON BIOMARKER-BASED DIAGNOSTIC TESTS TO DRIVE MARKET GROWTH
・ TABLE 6........ HUMAN MICROBIOME MARKET FOR DIAGNOSTICS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 7........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTICS,
BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 8 EUROPE: HUMAN MICROBIOME MARKET FOR DIAGNOSTICS, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 9............. ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR DIAGNOSTICS,
BY COUNTRY 2023–2029 (USD MILLION)
7.... HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 10.. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
7.2 GENOMICS
・ TABLE 11 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS,
BY TYPE, 2021–2029 (USD MILLION)
・ TABLE 12 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS,
BY REGION, 2021–2029 (USD MILLION)
・ TABLE 13......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 14..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 15 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY COUNTRY, 2021–2029 (USD MILLION) 65
7.2.1 SEQUENCING
・ TABLE 16 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING,
BY REGION, 2021–2029 (USD MILLION)
・ TABLE 17......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 18..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 19 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 20 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING,
BY METHOD, 2021–2029 (USD MILLION)
7.2.1.1 16S RRNA SEQUENCING METHOD
7.2.1.1.1 COST-EFFECTIVENESS TO PROPEL IDENTIFICATION OF BACTERIAL STRAINS
・ TABLE 21 16S RRNA SEQUENCING METHOD, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 22.... NORTH AMERICA: 16S RRNA SEQUENCING METHOD, BY COUNTRY,
2018–2025 (USD MILLION)
・ TABLE 23. EUROPE: 16S RRNA SEQUENCING METHOD, BY COUNTRY,
2021–2029 (USD MILLION)
・ TABLE 24......... ASIA PACIFIC: 16S RRNA SEQUENCING METHOD, BY COUNTRY,
2021–2029 (USD MILLION)
7.2.1.2 WHOLE-GENOME SEQUENCING (WGS)METHOD
7.2.1.2.1 WGS TO GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION
・ TABLE 25..... WGS METHOD, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 26 NORTH AMERICA: WGS METHOD, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 27... EUROPE: WGS METHOD, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 28.... ASIA PACIFIC: WGS METHOD, BY COUNTRY, 2021–2029 (USD MILLION)
7.2.1.3 OTHER SEQUENCING METHODS
・ TABLE 29.. OTHER SEQUENCING METHODS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 30....... NORTH AMERICA: OTHER SEQUENCING METHODS, BY COUNTRY,
2021–2029 (USD MILLION)
・ TABLE 31.... EUROPE: OTHER SEQUENCING METHODS, BY COUNTRY,
2021–2029 (USD MILLION)
・ TABLE 32 ASIA PACIFIC: OTHER SEQUENCING METHODS BY COUNTRY,
2021–2029 (USD MILLION)
7.2.2 OTHER GENOMIC TECHNOLOGIES
・ TABLE 33 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY REGION, 2021–2029 (USD MILLION). 71
・ TABLE 34......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 35..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 36 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2021–2029 (USD MILLION)
7.3 PROTEOMICS
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN PROTEOMIC TECHNOLOGIES TO DRIVE MARKET GROWTH
・ TABLE 37...... PROTEOMICS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 38 NORTH AMERICA: PROTEOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 39... EUROPE: PROTEOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 40.... ASIA PACIFIC: PROTEOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
7.4 METABOLOMICS
7.4.1 ADVANTAGES OF METABOLOMICS OVER GENOMICS AND PROTEOMICS TO DRIVE MARKET GROWTH
・ TABLE 41.. METABOLOMICS, BY REGION, 2021–2029 (USD MILLION)
・ TABLE 42............ NORTH AMERICA: METABOLOMICS, BY COUNTRY,
2021–2029 (USD MILLION)
・ TABLE 43 EUROPE: METABOLOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
・ TABLE 44 ASIA PACIFIC: METABOLOMICS, BY COUNTRY, 2021–2029 (USD MILLION)
8.... HUMAN MICROBIOME MARKET, BY TYPE
8.1 INTRODUCTION
・ TABLE 45 HUMAN MICROBIOME MARKET, BY TYPE, 2023–2029 (USD MILLION)
8.2 MICROBIOME CONSORTIA TRANSPLANTATION (FMT)
8.2.1 ADVANCEMENTS IN CLINICAL TRIALS FOR C. DIFFICILE INFECTION TREATMENT TO AUGMENT SEGMENTAL GROWTH
・ TABLE 46........... HUMAN MICROBIOME MARKET FOR MICROBIOME CONSORTIA TRANSPLANTATION (FMT), BY REGION, 2023–2029 (USD MILLION)
・ TABLE 47...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR MICROBIOME CONSORTIA TRANSPLANTATION (FMT), BY COUNTRY
2023–2029 (USD MILLION)
・ TABLE 48 EUROPE: HUMAN MICROBIOME MARKET FOR MICROBIOME CONSORTIA TRANSPLANTATION (FMT), BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 49........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR MICROBIOME CONSORTIA TRANSPLANTATION (FMT), BY COUNTRY 2023–2029 (USD MILLION)
8.3 PEPTIDE
8.3.1 POTENTIAL OF PEPTIDES IN REDUCING NEURODEGENERATIVE DISORDERS TO GROW IN FORECAST PERIOD
・ TABLE 50.. HUMAN MICROBIOME MARKET FOR PEPTIDE, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 51...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PEPTIDE, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 52. EUROPE: HUMAN MICROBIOME MARKET FOR PEPTIDE, BY COUNTRY
2023–2029 (USD MILLION)
・ TABLE 53 ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR PEPTIDE, BY COUNTRY 2023–2029 (USD MILLION)
8.4 LIVE BIOTHERAPEUTIC PRODUCT
8.4.1 GROWING R&D INVESTMENTS FOR LIVE BIOTHERAPEUTIC
PRODUCTS TO BOOST SEGMENTAL GROWTH
・ TABLE 54 HUMAN MICROBIOME MARKET FOR LIVE BIOTHERAPEUTIC PRODUCT,
BY REGION, 2023–2029 (USD MILLION)
・ TABLE 55 NORTH AMERICA: HUMAN MICROBIOME MARKET FOR LIVE BIOTHERAPEUTIC PRODUCT, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 56............ EUROPE: HUMAN MICROBIOME MARKET FOR LIVE BIOTHERAPEUTIC PRODUCT, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 57..... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR LIVE BIOTHERAPEUTIC PRODUCT, BY COUNTRY 2023–2029 (USD MILLION)
8.5 OTHERS
8.5.1 INCREASING FOCUS ON SMALL MOLECULES TO PROPEL
SEGMENTAL GROWTH
・ TABLE 58.. HUMAN MICROBIOME MARKET FOR OTHERS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 59...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHERS, BY COUNTRY 2023–2029 (USD MILLION)
・ TABLE 60.. EUROPE: HUMAN MICROBIOME MARKET FOR OTHERS, BY COUNTRY
2023–2029 (USD MILLION)
・ TABLE 61 ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR OTHERS, BY COUNTRY 2023–2029 (USD MILLION)
9.... HUMAN MICROBIOME MARKET, BY PRODUCT
9.1 INTRODUCTION
・ TABLE 62 HUMAN MICROBIOME MARKET, BY PRODUCT, 2023–2029 (USD MILLION)
9.2 DRUGS
9.2.1 INCREASING NUMBER OF MICROBIOME-BASED DRUGS
IN PIPELINE TO DRIVE SEGMENT GROWTH
・ TABLE 63... HUMAN MICROBIOME MARKET FOR DRUGS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 64...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DRUGS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 65... EUROPE: HUMAN MICROBIOME MARKET FOR DRUGS, BY COUNTRY,
2023–2029 (USD MILLION)
・ TABLE 66 ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR DRUGS, BY COUNTRY, 2023–2029 (USD MILLION)
9.3 DIAGNOSTIC TESTS
9.3.1 GROWING CONSUMER AWARENESS ABOUT MICROBIOME- BASED TESTS TO DRIVE SEGMENT GROWTH
・ TABLE 67 HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 68...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 69 EUROPE: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 70........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS,
BY COUNTRY, 2023–2029 (USD MILLION)
9.4 PROBIOTICS
9.4.1 ONGOING RESEARCH PROMOTING CREDIBILITY REGARDING HEALTH CLAIMS AND SAFETY OF PROBIOTICS
・ TABLE 71........ HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 72...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PROBIOTICS,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 73 EUROPE: HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 74........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR PROBIOTICS,
BY COUNTRY, 2023–2029 (USD MILLION)
9.5 PREBIOTICS
9.5.1 DEVELOPMENT OF TARGETED PREBIOTICS IN ENHANCING GUT MICROBIOTA TO DRIVE SEGMENT GROWTH
・ TABLE 75......... HUMAN MICROBIOME MARKET FOR PREBIOTICS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 76...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PREBIOTICS,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 77 EUROPE: HUMAN MICROBIOME MARKET FOR PREBIOTICS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 78........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR PREBIOTICS,
BY COUNTRY, 2023–2029 (USD MILLION)
9.6 OTHER PRODUCTS
・ TABLE 79. HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 80...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 81........ EUROPE: HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 82.. ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS,
BY COUNTRY, 2023–2029 (USD MILLION)
10.. HUMAN MICROBIOME MARKET, BY DISEASE
10.1 INTRODUCTION
・ TABLE 83.. HUMAN MICROBIOME MARKET, BY DISEASE, 2023–2029 (USD MILLION)
10.2 INFECTIOUS DISEASES
10.2.1 INCREASING NUMBER OF CLINICAL STUDIES FOR CLOSTRIDIUM DIFFICILE INFECTION TO DRIVE SEGMENT GROWTH
・ TABLE 84.. DEVELOPMENT OF MICROBIOME-BASED ANTI-BACTERIAL DRUGS FOR INFECTIOUS DISEASES
・ TABLE 85 HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2029 (USD MILLION)
・ TABLE 86...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 87. EUROPE: HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 88........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
10.3 GASTROINTESTINAL DISEASES
10.3.1 INCREASING NUMBER OF CLINICAL STUDIES FOR GASTROINTESTINAL DISEASES TO DRIVE SEGMENT GROWTH
・ TABLE 89... HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES,
BY REGION, 2023–2029 (USD MILLION)
・ TABLE 90...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 91................. EUROPE: HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 92........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2029 (USD MILLION)
10.4 ENDOCRINE & METABOLIC DISORDERS
10.4.1 DEVELOPMENT OF MICROBIOME MODULATORS FOR TREATMENT OF METABOLIC DISORDERS TO DRIVE SEGMENT GROWTH.. 101
・ TABLE 93........ DEVELOPMENT OF MICROBIOME-BASED PRODUCTS
FOR METABOLIC DISEASES
・ TABLE 94........... HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY REGION, 2023–2029 (USD MILLION)
・ TABLE 95...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 96. EUROPE: HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 97........... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY COUNTRY, 2023–2029 (USD MILLION)
10.5 CANCER
10.5.1 MICROBIOME-BASED PRODUCTS HAVE DEMONSTRATED EFFICACY
IN TREATMENT OF PELVIC AND COLON CANCER
・ TABLE 98.. HUMAN MICROBIOME MARKET FOR CANCER, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 99...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR CANCER,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 100 EUROPE: HUMAN MICROBIOME MARKET FOR CANCER, BY COUNTRY,
2023–2029 (USD MILLION)
・ TABLE 101......... ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR CANCER, BY COUNTRY, 2023–2029 (USD MILLION)
10.6 OTHER DISEASES
・ TABLE 102 HUMAN MICROBIOME MARKET FOR OTHER DISEASES, BY REGION,
2023–2029 (USD MILLION)
・ TABLE 103.... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 104...... EUROPE: HUMAN MICROBIOME MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2029 (USD MILLION)
・ TABLE 105 ASIA PACIFIC: HUMAN MICROBIOME MARKET FOR OTHER DISEASES,
BY COUNTRY, 2023–2029 (USD MILLION)
11.. HUMAN MICROBIOME MARKET, BY REGION
11.1 INTRODUCTION
・ TABLE 106. HUMAN MICROBIOME MARKET, BY REGION, 2023–2029 (USD MILLION)
11.2 NORTH AMERICA
・ FIGURE 16.......... NORTH AMERICA: HUMAN MICROBIOME MARKET SNAPSHOT
・ TABLE 107...... NORTH AMERICA: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 108...... NORTH AMERICA: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 109...... NORTH AMERICA: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
・ TABLE 110...... NORTH AMERICA: HUMAN MICROBIOME MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
11.2.1 US
11.2.1.1 INCREASING INVESTMENTS BY NIH IN SUPPORT OF MICROBIOME RESEARCH TO DRIVE MARKET GROWTH
・ TABLE 111.......... US: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 112..... US: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 113... US: HUMAN MICROBIOME MARKET, BY DISEASE, 2023-2029 (USD MILLION)
11.2.2 CANADA
11.2.2.1 INCREASING GOVERNMENT SUPPORT AND FUNDS TO SUPPORT MARKET GROWTH
・ TABLE 114. INDICATIVE LIST OF PROJECTS ON HUMAN MICROBIOME IN 2018
・ TABLE 115.. CANADA: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 116................. CANADA: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 117.... CANADA: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.3 EUROPE
・ FIGURE 17...... EUROPE: HUMAN MICROBIOME MARKET SNAPSHOT
・ TABLE 118........................................ EU MICROBIOME PROJECT
・ TABLE 119... EUROPE: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 120................. EUROPE: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 121.... EUROPE: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
・ TABLE 122... EUROPE: HUMAN MICROBIOME MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 EXTENDED APPLICATIONS OF MICROBIOME RESEARCH TO THERAPEUTIC AREAS TO BOOST ADOPTION OF MICROBIOME-BASED PRODUCTS
・ TABLE 123 GERMANY: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 124............... GERMANY: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 125.. GERMANY: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.3.2 UK
11.3.2.1 INCREASING FOCUS ON MICROBIOME-BASED PRODUCTS DEVELOPMENT TO DRIVE MARKET GROWTH
・ TABLE 126.......... UK: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 127..... UK: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 128... UK: HUMAN MICROBIOME MARKET, BY DISEASE, 2023-2029 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 INCREASING FUNDING TO BOOST MICROBIOME-BASED PRODUCTS DEVELOPMENT. 120
・ TABLE 129... FRANCE: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 130................. FRANCE: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 131.... FRANCE: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.3.4 ROE
・ TABLE 132........ ROE: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 133... ROE: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 134.......... ROE: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.4 ASIA PACIFIC
・ FIGURE 18 ASIA PACIFIC: HUMAN MICROBIOME MARKET SNAPSHOT
・ TABLE 135........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 136........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 137........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
・ TABLE 138........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY COUNTRY,
2023–2029 (USD MILLION)
11.4.1 CHINA
11.4.1.1 LARGE NUMBER OF HUMAN MICROBIOME RESEARCH STUDIES
TO DRIVE MARKET GROWTH
・ TABLE 139..... INDICATIVE LIST OF HUMAN MICROBIOME RESEARCH STUDIES CONDUCTED IN CHINA
・ TABLE 140..... CHINA: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 141. CHINA: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 142....... CHINA: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 INCREASING FOCUS ON FUNDING FOR MICROBIOME-BASED PRODUCTS TO DRIVE MARKET GROWTH
・ TABLE 143..... JAPAN: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 144. JAPAN: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 145....... JAPAN: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.4.3 INDIA
11.4.3.1 GOVERNMENT FUNDING TO DRIVE MICROBIOME-BASED PRODUCTS DEVELOPMENT. 128
・ TABLE 146...... INDIA: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 147. INDIA: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 148........ INDIA: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
・ TABLE 149.. ROAPAC: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 150................. ROAPAC: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 151.... ROAPAC: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
11.5 REST OF THE WORLD (ROW)
・ TABLE 152....... ROW: HUMAN MICROBIOME MARKET, BY PRODUCT,
2023–2029 (USD MILLION)
・ TABLE 153... ROW: HUMAN MICROBIOME MARKET, BY APPLICATION,
2023–2029 (USD MILLION)
・ TABLE 154......... ROW: HUMAN MICROBIOME MARKET, BY DISEASE,
2023-2029 (USD MILLION)
12.. COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 PRODUCT TYPE FOOTPRINT OF COMPANIES
・ TABLE 155......................... PRODUCT TYPE PORTFOLIO ANALYSIS:
HUMAN MICROBIOME MARKET (2021)
12.3 CLINICAL PHASE FOOTPRINT OF COMPANIES
・ TABLE 156................ CLINICAL PHASE FOOTPRINT OF COMPANIES:
HUMAN MICROBIOME MARKET (2021)
12.4 DISEASE FOOTPRINT OF COMPANIES
・ TABLE 157............... DISEASE FOOTPRINT OF COMPANIES: HUMAN MICROBIOME MARKET (2021)
12.5 COMPETITIVE SCENARIO
・ TABLE 158..... HUMAN MICROBIOME MARKET: KEY DEALS, JANUARY 2020–JANUARY 2021
13.. COMPANY PROFILES
13.1 MAJOR PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
13.1.1 ENTEROME
・ TABLE 159.............................. ENTEROME: BUSINESS OVERVIEW
13.1.2 SERES THERAPEUTICS
・ TABLE 160................ SERES THERAPEUTICS: BUSINESS OVERVIEW
・ FIGURE 19...... SERES THERAPEUTICS: COMPANY SNAPSHOT (2021)
13.1.3 4D PHARMA PLC
・ TABLE 161....................... 4D PHARMA PLC: BUSINESS OVERVIEW
・ FIGURE 20............. 4D PHARMA PLC: COMPANY SNAPSHOT (2020)
13.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC.
・ TABLE 162............ INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
・ FIGURE 21............ INTERNATIONAL FLAVORS & FRAGRANCES INC.:
COMPANY SNAPSHOT (2021)
13.1.5 OPTIBIOTIX HEALTH PLC.
・ TABLE 163............. OPTIBIOTIX HEALTH PLC.: BUSINESS OVERVIEW
・ FIGURE 22... OPTIBIOTIX HEALTH PLC.: COMPANY SNAPSHOT (2020)
・ TABLE 164.............................................. PRODUCT LAUNCHES.. 152
13.1.6 SYNLOGIC, INC.
・ TABLE 165............................... SYNLOGIC: BUSINESS OVERVIEW
・ FIGURE 23.............. SYNLOGIC, INC.: COMPANY SNAPSHOT (2020)
13.1.7 SECOND GENOME INC.
・ TABLE 166............... SECOND GENOME INC.: BUSINESS OVERVIEW
13.1.8 VEDANTA BIOSCIENCES, INC.
・ TABLE 167....... VEDANTA BIOSCIENCES, INC.: BUSINESS OVERVIEW
13.1.9 FERRING PHARMACEUTICALS
・ TABLE 168...... FERRING PHARMACEUTICALS: BUSINESS OVERVIEW
13.1.10 EVELO BIOSCIENCES, INC.
・ TABLE 169.................. EVELO BIOSCIENCES: BUSINESS OVERVIEW
・ FIGURE 24. EVEL0 BIOSCIENCES, INC.: COMPANY SNAPSHOT (2020)
13.1.11 BIOMX
・ TABLE 170.................................... BIOMX: BUSINESS OVERVIEW
・ FIGURE 25 BIOMX: COMPANY SNAPSHOT (2020)
13.1.12 YSOPIA BIOSCIENCE
・ TABLE 171.................. YSOPIA BIOSCIENCE: BUSINESS OVERVIEW
13.1.13 KALEIDO BIOSCIENCES, INC.
・ TABLE 172........ KALEIDO BIOSCIENCES, INC.: BUSINESS OVERVIEW
・ FIGURE 26....... KALEIDO BIOSCIENCES, INC.: COMPANY SNAPSHOT (2020)
13.1.14 FLIGHTPATH BIOSCIENCES, INC. 171
・ TABLE 173... FLIGHTPATH BIOSCIENCES, INC.: BUSINESS OVERVIEW
13.1.15 FINCH THERAPEUTICS GROUP, INC.
・ TABLE 174 FINCH THERAPEUTICS GROUP, INC.: BUSINESS OVERVIEW
・ FIGURE 27 FINCH THERAPEUTICS GROUP, INC.: COMPANY SNAPSHOT (2020)
13.1.16 QUANTBIOME, INC. (DBA OMBRE). 174
・ TABLE 175.................... QUANTBIOME, INC.: BUSINESS OVERVIEW
13.1.17 VIOME LIFE SCIENCES, INC.
・ TABLE 176......... VIOME LIFE SCIENCES, INC.: BUSINESS OVERVIEW
13.1.18 BIOHM HEALTH
・ TABLE 177......................... BIOHM HEALTH: BUSINESS OVERVIEW
13.2 OTHER COMPANIES
13.2.1 DAYTWO
・ TABLE 178.................................. DAYTWO: COMPANY OVERVIEW
13.2.2 ATLAS BIOMED
・ TABLE 179......................... ATLAS BIOMED: COMPANY OVERVIEW
13.2.3 BIONE
・ TABLE 180..................................... BIONE: COMPANY OVERVIEW
13.2.4 LUXIA SCIENTIFIC.. 180
・ TABLE 181...................... LUXIA SCIENTIFIC: COMPANY OVERVIEW
13.2.5 METABIOMICS
・ TABLE 182.......................... METABIOMICS: COMPANY OVERVIEW
13.2.6 SUN GENOMICS
・ TABLE 183..... SUN GENOMICS: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.. APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS